Product center

Yocon is committed to produce high-quality and brand serum-free cell culture products, laying a solid foundation for cell culture media solutions.

Single-Nuclear Cell Cryopreservation Solution 2.0 (rHSA)

· Newly upgraded cryopreservation solution dedicated for single-nuclear cells, superior cell function, better compatibility · Higher recovery rate, superior cell function, better compatibility

Product use

Single-Nuclear Cell Cryopreservation Solution 2.0 (rHSA) is used for cryopreservation of peripheral blood mononuclear cells (PBMC) and umbilical cord blood mononuclear cells (CBMC). The recovered cells retain excellent viability and biological function, suitable for NK cell induction and expansion, CAR-T/CAR-NK development, immunology research, IIT and cell therapy related preclinical studies.
Product video


Product NameCatalog No.SpecificationStorage ConditionApplication
Single-Nuclear Cell Cryopreservation Solution 2.0 (rHSA)NC0605100 mL/bottleStore at 2–8°C, protected from light, valid for 12 monthsFor cryopreservation of single-nuclear cells derived from peripheral blood / umbilical cord blood


Product Advantages


  • Recombinant human albumin system, serum-free, free of human-derived and animal-derived components for enhanced biosafety.

  • Newly optimized formulation with composite protection system, stronger ice crystal inhibition, reduced oxidative damage, cell recovery rate >80%, and post-thaw cell function restored to over 90% of fresh cells.

  • Ready-to-use cryopreservation medium with no additional supplements required; supports high-density cryopreservation at 2E7 cells/mL.



Product Performance


1. Short-term Cryopreservation: High Recovery & High Viabilit


image.png


For samples from different sources, Yocon cryopreservation solution achieves higher cell recovery than competing brands; after short-term cryopreservation and thawing of PBMC / CBMC, cell recovery rate >80% and viability >90%.


2. Long-term Cryopreservation: Stable Viability & Excellent Performance


image.png


After long-term cryopreservation (30 days) of peripheral blood PBMC, cell recovery rate (>80%) and viability (>90%) remain stable with no obvious decline, outperforming Brand A.


3. Culture Cases of Cryopreserved Samples


image.png


After short-term /long-term cryopreservation, peripheral blood PBMC were induced into NK cells. After 14 days of expansion culture, NK phenotype purity >98%, cell density >4E6/mL, and expansion capacity is comparable to the short-term cryopreservation group.


image.png


Note: The special sample was heavily contaminated with red blood cells, with granulocytes accounting for 0.39%.


After short-term cryopreservation, umbilical cord blood CBMC were cultured for 20 days for NK induction. NK phenotype purity >90%, superior to the fresh group. Normal samples reach a culture density over 4E6/mL; the special sample also exceeds 2.8E6/mL. Yocon cryopreservation solution performs better than the fresh group and competitors for this challenging special sample.



Product advantages

Data download